VivoSim Labs, INC.
VIVS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001497253
In the last 90 days, VivoSim Labs, INC. insiders filed 1 open-market purchase and 0 sales; 25 institutions reported holding it in 13F filings for Q2 2026, worth $109.7K in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding VivoSim Labs, INC. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 31 | 1 | 32 | +2 |
| Shares | 2.44M | 19.6K | 2.49M | +73.0K (+3.0%) |
| Value | $1.24M | $9.99K | $1.15M | −$85.2K (−6.9%) |
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held VivoSim Labs, INC. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Raymond James Financial Inc | 39,585 | $18.2K | 0.00% |
| Wedbush Securities Inc | 18,807 | $9.00K | 0.00% |
| SBI Securities Co., Ltd. | 1,885 | $867 | 0.00% |
| Golden State Wealth Management, LLC | 25 | $11 | 0.00% |
| Cullen/Frost Bankers, Inc. | 20 | $9 | 0.00% |
| Ameriflex Group, Inc. | 5 | $2 | 0.00% |
Sold out (4)
Institutions that held VivoSim Labs, INC. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Two Sigma Securities, LLC | 15,169 | $7.72K |
| Russell Investments Group, Ltd. | 2,515 | $1.28K |
| Citadel Advisors LLC | 2,338 | $1.19K |
| Quintet Private Bank (Europe) S.A. | 500 | $254 |
Not filed for Q4 2024 yet (1)
Institutions that held VivoSim Labs, INC. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Raymond James & Associates | 19,622 | $9.99K |